publication date: Nov. 26, 2014
20141126 - Nov. 26, 2014

Urgent FDA Action Turns Power Morcellation Into Rarely Used Gynecological Procedure

The power morcellator should no longer be used for hysterectomies or fibroid removal in the vast majority of women getting these procedures, FDA declared in a highly anticipated guidance document Nov. 24.

Using a new authority that bypasses public comment, the agency stopped short of imposing an outright ban on the device, but severely restricted its use.

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

The Brigham & Women’s Hospital has halted a controversial study that combined power morcellators with “containment bags” intended to capture tissue during minimally invasive gynecological surgery.

Launched earlier this summer, the study was designed to enroll 400 women to test dye leakage in several commercially available bags that have not been cleared by FDA for use with power morcellators.

Linda Weiss, director of NCI Office of Cancer Centers, to Retire in March 2015

Linda Weiss said she intends to retire from her job as director of the NCI Office of Cancer Centers.

Weiss’s retirement was announced in an email from NCI Director Harold Varmus Nov. 25.

Copyright (c) 2020 The Cancer Letter Inc.